Amlyn co-founder Sells 3,846 Shares |
|
|
|
Published
:
Tue, 09 Jan 2007 23:08
|
NEW YORK - The co-founder and director of biopharmaceutical company Amylin Pharmaceuticals Inc. sold 3,846 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing Monday.In a Form 4 filed with the SEC, Howard E. Greene Jr. reported he sold the shares Monday for $38.16 apiece.The stock sale was conducted under a prearranged 10b5-1 trading plan which allows a company insider to set up a program in advance for such transactions and proceed with them even if he or she comes into possession of material nonpublic information.Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.Amlyn Pharmaceuticals is based in San Diego.Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
Print this Story
easyJet in another round of acquisition turmoil 